ACHE and Alzheimer disease: Acetylcholinesterase inhibitors (AChEIs), which increase the synaptic amount of ACh by preventing its degradation, constitute the best-developed and widely approved class of AD drugs [10–13] and are used for mild-to-moderate stages of the disease.